牛皮的严重程度,并发症负担和生物疗法:使用查尔森并发症指数的多中心观察研究
Nicoletta Bernardini1, Annunziata Dattola2, Giuseppe Paolo Antonio Gemma2
1Dermatology Unit, ASL Latina, Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
The Journal of dermatological treatment
|September 24, 2025
概括
牛皮的严重程度与较高的并发症负担相关,强调需要进行心血管查. 生物疗法可能会以不同的方式影响并发症的进展,这表明牛皮患者的个性化治疗.
科学领域:
- 皮肤病学和免疫学
- 临床流行病学临床流行病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮是一种与系统性并发症相关的慢性炎症性疾病.
- 查尔森并发症指数 (CCI) 衡量并发症负担和存活率,但其与牛皮严重程度和生物治疗的关系尚不清楚.
研究的目的:
- 为了研究牛皮病严重程度和并发症之间的关联.
- 评估生物疾病修饰性抗风湿药物 (bDMARDs) 的影响,特别是阿达利穆马布 (ADA),瑞桑基祖马布 (RISA) 和塞库金乌马布 (SECU) 对CCI的影响.
- 为了估计与对照组相比,牛皮患者的10年生存期.
主要方法:
- 一项多中心,横截面研究,涉及343名牛皮患者和343名来自意大利13个中心的匹配对照.
- 根据牛皮区域和严重性指数 (PASI) 得分和bDMARD治疗组,分析了CCI得分和并发症概况.
- 使用预测模型估计了生存概率.
主要成果:
- 牛皮患者的年龄调整CCI显著高于对照组 (p=0.021),特别是那些患有严重牛皮 (PASI>10; p=0.003) 的患者.
- 周围血管疾病,脑血管疾病和心肌梗塞与牛皮的严重程度相关.
- 与接受RISA或SECU治疗的患者相比,接受ADA治疗的患者的CCI较低 (p<0.05).
结论:
- 牛皮的严重程度与伴随性疾病负担的增加有关,这强调了心血管和代谢查的重要性.
- 生物疗法可能会以不同的方式影响并发性疾病的进展,支持个人化治疗策略来治疗牛皮.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
492
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
492
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Inflammatory Bowel Disease II: Crohn's Disease
960
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
960
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643
Chronic Pancreatitis II: Collaborative Care
313
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
313


